{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T05:48:45Z","timestamp":1712900925639},"reference-count":42,"publisher":"Geotar-Media Publishing Group","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Angiol Sosud Khir"],"published-print":{"date-parts":[[2019]]},"DOI":"10.33529\/angio2019324","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T15:48:32Z","timestamp":1568130512000},"page":"39","source":"Crossref","is-referenced-by-count":2,"title":["State of the art of stem cell therapy for ischaemic cardiomyopathy. Part 1"],"prefix":"10.33029","volume":"25","author":[{"given":"M.","family":"Maslovaric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Fatic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Delevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18453","reference":[{"key":"key-10.33529\/ANGIO2019324-1","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000441139.02102.80"},{"key":"key-10.33529\/ANGIO2019324-2","doi-asserted-by":"publisher","DOI":"10.2217\/fca.10.109"},{"key":"key-10.33529\/ANGIO2019324-3","doi-asserted-by":"crossref","unstructured":"Beltrami A.P., Barlucchi L., Torellaetal D. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 6: 763\u2013776.","DOI":"10.1016\/S0092-8674(03)00687-1"},{"key":"key-10.33529\/ANGIO2019324-4","unstructured":"Hosoda T. C-kit-positive cardiac stem cells and myocardial regeneration. American Journal of Cardiovascular Disease. 2012; 2: 1: 58\u201367."},{"key":"key-10.33529\/ANGIO2019324-5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500169102"},{"key":"key-10.33529\/ANGIO2019324-6","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v6.i7.610"},{"key":"key-10.33529\/ANGIO2019324-7","doi-asserted-by":"crossref","unstructured":"Pangonyte D., Stalioraityte E., Ziuraitiene R., et al. Cardiomyocyte remodeling in ischemic heart disease. Medicina (Kaunas). 2008; 44: 11: 848\u2013854.","DOI":"10.3390\/medicina44110107"},{"key":"key-10.33529\/ANGIO2019324-8","doi-asserted-by":"crossref","unstructured":"Pangonyte D., Stalioraityte E., Kazlauskaite D., et al. Changes of heart geometry in patients with ischemic heart disease. Medicina. 2008; 44: 1: 8\u201314.","DOI":"10.3390\/medicina44010002"},{"key":"key-10.33529\/ANGIO2019324-9","doi-asserted-by":"crossref","unstructured":"Michler R.E. Stem cell therapy for heart failure. Methodist DeBakey Cardiovascular Journal. 2013; 9: 4: 187\u2013194.","DOI":"10.14797\/mdcj-9-4-187"},{"key":"key-10.33529\/ANGIO2019324-10","doi-asserted-by":"crossref","unstructured":"Gnecchi M., Danieli P., Cervio E. Mesenchymal stem cell therapy for heart disease. Vascular Pharmacology. 2012; 57: 1: 48\u201355.","DOI":"10.1016\/j.vph.2012.04.002"},{"key":"key-10.33529\/ANGIO2019324-11","unstructured":"Stefanovi\u0107 R. Oboljenja sr\u010danog mi\u0161i\u0107a (miokarda): miokarditisi i miokardiopatije. Specijalna klini\u010dka fiziologija. 1988; 329\u2013335."},{"key":"key-10.33529\/ANGIO2019324-12","unstructured":"Different heart diseases. World heart federation. 29 May 2017."},{"key":"key-10.33529\/ANGIO2019324-13","unstructured":"Ischemic cardiomyopathy. Cleveland Clinic."},{"key":"key-10.33529\/ANGIO2019324-14","doi-asserted-by":"crossref","unstructured":"Healy L., Ruban L. Atlas of Human Pluripotent Stem Cells in Culture. New York: Springer Science. 2015; 198.","DOI":"10.1007\/978-1-4899-7507-2"},{"key":"key-10.33529\/ANGIO2019324-15","unstructured":"Lanza R., Atala A. Essentials of Stem Cell Biology. Cambridge: Academic Press. 2014; 712."},{"key":"key-10.33529\/ANGIO2019324-16","doi-asserted-by":"publisher","DOI":"10.1177\/1087057112438507"},{"key":"key-10.33529\/ANGIO2019324-17","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M900195-MCP200"},{"key":"key-10.33529\/ANGIO2019324-18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00123"},{"key":"key-10.33529\/ANGIO2019324-19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500169102"},{"key":"key-10.33529\/ANGIO2019324-20","doi-asserted-by":"crossref","unstructured":"Leone A.M., Rutella S., Bonanno G., et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur. Heart. J. 2005; 26: 12: 1196\u20131204.","DOI":"10.1093\/eurheartj\/ehi164"},{"key":"key-10.33529\/ANGIO2019324-21","doi-asserted-by":"publisher","DOI":"10.1038\/415234a"},{"key":"key-10.33529\/ANGIO2019324-22","doi-asserted-by":"crossref","unstructured":"Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001; 103: 23: 2776\u20132779.","DOI":"10.1161\/hc2301.092122"},{"key":"key-10.33529\/ANGIO2019324-23","doi-asserted-by":"crossref","unstructured":"Wang Y., T\u00e4gil K., Ripa R.S., et al. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. Int. J. Cardiol. 2005; 100: 3: 477\u2013483.","DOI":"10.1016\/j.ijcard.2004.12.006"},{"key":"key-10.33529\/ANGIO2019324-24","doi-asserted-by":"crossref","unstructured":"Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trail. Lancet. 2004; 364: 141\u2013148.","DOI":"10.1016\/S0140-6736(04)16626-9"},{"key":"key-10.33529\/ANGIO2019324-25","doi-asserted-by":"crossref","unstructured":"Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001; 7: 4: 430\u2013436.","DOI":"10.1038\/86498"},{"key":"key-10.33529\/ANGIO2019324-26","doi-asserted-by":"crossref","unstructured":"Gao J., Dennis J.E., Muzic R.F., et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001; 169: 1: 12\u201320.","DOI":"10.1159\/000047856"},{"key":"key-10.33529\/ANGIO2019324-27","unstructured":"Thompson C.A., Nasseri B.A., Makower J., et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J. Am. Coll. Cardiol. 2003; 41: 11: 1964\u20131971."},{"key":"key-10.33529\/ANGIO2019324-28","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Avil\u00e9s F., San Rom\u00e1n J.A., Garc\u00eda-Frade J., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 2004; 95: 7: 742\u2013748.","DOI":"10.1161\/01.RES.0000144798.54040.ed"},{"key":"key-10.33529\/ANGIO2019324-29","unstructured":"Siminiak T., Grygielska B., Jerzykowska O., et al. Autologous bone marrow stem cell transplantation in acute myocardial infarction \u2013 report on two cases. Kardiol. Pol. 2003; 59: 12: 502\u2013510."},{"key":"key-10.33529\/ANGIO2019324-30","doi-asserted-by":"crossref","unstructured":"Assmus B., Sch\u00e4chinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002; 106: 24: 3009\u20133017.","DOI":"10.1161\/01.CIR.0000043246.74879.CD"},{"key":"key-10.33529\/ANGIO2019324-31","doi-asserted-by":"crossref","unstructured":"Strauer B.E., Brehm M., Zeus T., et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr. 2001; 126: 34: 932\u2013938.","DOI":"10.1055\/s-2001-16579-2"},{"key":"key-10.33529\/ANGIO2019324-32","doi-asserted-by":"crossref","unstructured":"Herreros J., Pr\u00f3sper F., Perez A., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur. Heart. J. 2003; 24: 22: 2012\u20132020.","DOI":"10.1016\/j.ehj.2003.09.012"},{"key":"key-10.33529\/ANGIO2019324-33","doi-asserted-by":"crossref","unstructured":"Dib N., Michler R.E., Pagani F.D., et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation. 2005; 112: 12: 1748\u20131755.","DOI":"10.1161\/CIRCULATIONAHA.105.547810"},{"key":"key-10.33529\/ANGIO2019324-34","doi-asserted-by":"crossref","unstructured":"Siminiak T., Kalawski R., Fiszer D., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am. Heart J. 2004; 148: 3: 531\u2013537.","DOI":"10.1016\/j.ahj.2004.03.043"},{"key":"key-10.33529\/ANGIO2019324-35","doi-asserted-by":"crossref","unstructured":"Pagani F.D., DerSimonian H., Zawadzka A., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 2003; 41: 5: 879\u2013888.","DOI":"10.1016\/S0735-1097(03)00081-0"},{"key":"key-10.33529\/ANGIO2019324-36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060186"},{"key":"key-10.33529\/ANGIO2019324-37","doi-asserted-by":"crossref","unstructured":"Sherman W., Martens T.P., Viles-Gonzalez J.F., Siminiak T. Catheter-based delivery of cells to the heart. Nat. Clin. Pract. Cardiovasc. Med. 2006; 3 (Suppl 1): S57\u201364.","DOI":"10.1038\/ncpcardio0446"},{"key":"key-10.33529\/ANGIO2019324-38","doi-asserted-by":"crossref","unstructured":"Smits P.C., Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 2003; 42: 12: 2063\u20132069.","DOI":"10.1016\/j.jacc.2003.06.017"},{"key":"key-10.33529\/ANGIO2019324-39","doi-asserted-by":"crossref","unstructured":"Opie S.R., Dib N. Surgical and catheter delivery of autologous myoblasts in patients with congestive heart failure. Nat. Clin. Pract. Cardiovasc. Med. 2006; 3 (Suppl 1): S42\u2013S45.","DOI":"10.1038\/ncpcardio0399"},{"key":"key-10.33529\/ANGIO2019324-40","doi-asserted-by":"crossref","unstructured":"Kawamoto A., Tkebuchava T., Yamaguchi J., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003; 107: 461\u2013468.","DOI":"10.1161\/01.CIR.0000046450.89986.50"},{"key":"key-10.33529\/ANGIO2019324-41","doi-asserted-by":"crossref","unstructured":"Siminiak T., Fiszer D., Jerzykowska O., et al. Percutaneous transvenous transplantation of autologous myoblasts in the treatment of postinfarction heart failure: the POZNAN trial. Eur. Heart. J. 2004; 25 (Suppl): 264.","DOI":"10.1016\/S0167-5273(04)90019-8"},{"key":"key-10.33529\/ANGIO2019324-42","unstructured":"Smits P., Langenhove G., Schaar M., et al. Efficiency and retention of a percutaneous transendomyocardial injection of VEGF165 by a fluoroscopy guided transendomyocardial injection catheter. In XIVth World Congress of Cardiology. Sydney: NSW. 2002; 216."}],"container-title":["Angiology and vascular surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T02:26:20Z","timestamp":1664331980000},"score":1,"resource":{"primary":{"URL":"https:\/\/elibrary.ru\/item.asp?id=39188312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"alternative-id":["ANGIO2019324"],"URL":"https:\/\/doi.org\/10.33529\/angio2019324","relation":{},"ISSN":["1027-6661"],"issn-type":[{"value":"1027-6661","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}